Agomelatine facilitates positive versus negative affective processing in healthy volunteer models.

Agomelatine is a new antidepressant with a novel profile of pharmacological action. The clinical efficacy of agomelatine has been established in major depression, but its actions on emotional bias are unknown. Consequently, the current experimental study assessed the effect of agomelatine on emotion...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Psychopharmacology Vol. 25; no. 9; pp. 1159 - 1168
Autores principales: Harmer CJ, de Bodinat C, Dawson GR, Dourish CT, Waldenmaier L, Adams S, Cowen PJ, Goodwin GM, Harmer, Catherine J, de Bodinat, Christian, Dawson, Gerard R, Dourish, Colin T, Waldenmaier, Lara, Adams, Sally, Cowen, Philip J, Goodwin, Guy M
Formato: clinical trial research Journal Article
Publicado: Sage Publications Inc. Sep2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104588599&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104588599
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02698811
        3FD
      jtl: Journal of Psychopharmacology
      issn: 02698811
      maglogo: Y
    pubinfo:
      dt: Sep2011
      vid: 25
      iid: 9
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        104588599
        NLM20660010
        2011319375
        10.1177/0269881110376689
        NLM20660010
        104588599
      ppf: 1159
      ppct: 9
      formats:
      tig:
        atl: Agomelatine facilitates positive versus negative affective processing in healthy volunteer models.
      aug:
        au:
          Harmer CJ
          de Bodinat C
          Dawson GR
          Dourish CT
          Waldenmaier L
          Adams S
          Cowen PJ
          Goodwin GM
          Harmer, Catherine J
          de Bodinat, Christian
          Dawson, Gerard R
          Dourish, Colin T
          Waldenmaier, Lara
          Adams, Sally
          Cowen, Philip J
          Goodwin, Guy M
        affil: Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK
      sug:
        subj:
          Acetic Acids Pharmacodynamics
          Affect Drug Effects
          Antidepressive Agents Pharmacodynamics
          Emotions Drug Effects
          Acetic Acids Administration and Dosage
          Adolescence
          Adult
          Antidepressive Agents Administration and Dosage
          Dose-Response Relationship, Drug
          Double-Blind Studies
          Drug Design
          Facial Expression
          Female
          Human
          Male
          Memory Drug Effects
          Reflex Drug Effects
          Young Adult
          Adolescent: 13-18 years
          Adult: 19-44 years
          Female
          Male
      ab: Agomelatine is a new antidepressant with a novel profile of pharmacological action. The clinical efficacy of agomelatine has been established in major depression, but its actions on emotional bias are unknown. Consequently, the current experimental study assessed the effect of agomelatine on emotional processing in healthy volunteers using an Emotional Test Battery shown to be sensitive to serotonin and noradrenaline reuptake inhibitors. Volunteers were randomized to receive placebo, 25 mg or 50 mg of agomelatine over a 7-day period in a double-blind parallel groups design. Emotional processing (n = 48) was assessed on the morning of day 8 using the Emotional Test Battery which included facial expression recognition, emotional memory, attentional visual probe and emotion-potentiated startle. Mood and subjective state were monitored before and during treatment. Agomelatine (25 mg) decreased subjective ratings of sadness, reduced recognition of sad facial expressions, improved positive affective memory and reduced the emotion-potentiated startle response. The results show that agomelatine has more selective effects on the processing of social facial cues than conventional antidepressants, which could contribute to less blunting of emotional experience. The study highlights the potential value of volunteer models in drug development for screening and profiling of novel antidepressants.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N